Abound Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.1K | Buy |
1,117
+9
| +0.8% | +$218 | 0.01% | 282 |
|
2025
Q1 | $28.1K | Sell |
1,108
-183
| -14% | -$4.64K | 0.01% | 256 |
|
2024
Q4 | $34.2K | Buy |
1,291
+106
| +9% | +$2.81K | 0.01% | 216 |
|
2024
Q3 | $34.3K | Buy |
1,185
+16
| +1% | +$463 | 0.01% | 221 |
|
2024
Q2 | $32.7K | Buy |
1,169
+6
| +0.5% | +$168 | 0.01% | 201 |
|
2024
Q1 | $32.3K | Sell |
1,163
-29
| -2% | -$805 | 0.01% | 191 |
|
2023
Q4 | $34.3K | Buy |
1,192
+54
| +5% | +$1.55K | 0.01% | 182 |
|
2023
Q3 | $37.8K | Sell |
1,138
-263
| -19% | -$8.73K | 0.02% | 158 |
|
2023
Q2 | $51.4K | Sell |
1,401
-83
| -6% | -$3.04K | 0.02% | 127 |
|
2023
Q1 | $60.6K | Buy |
1,484
+136
| +10% | +$5.55K | 0.03% | 110 |
|
2022
Q4 | $69.1K | Sell |
1,348
-212
| -14% | -$10.9K | 0.03% | 86 |
|
2022
Q3 | $68.2K | Buy |
+1,560
| New | +$68.2K | 0.04% | 88 |
|